Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Elisa Assay Kit
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Elisa Assay Kit

[0639-abx055292] Human West Nile Virus IgG (WNV-IgG) ELISA Test 96t
Human West Nile Virus IgG (WNV-IgG) ELISA Test 96t
695.00 € 695.0 EUR
[0749-KTE60042-96T] Human Von Willebrand Factor (VWF) ELISA Test - 96 wells plate
Human Von Willebrand Factor (VWF) ELISA Test - 96 wells plate
815.00 € 815.0 EUR
[0772-E1402Hu] Human Vitamin D-binding protein, DBP ELISA Test - 96T
Human Vitamin D-binding protein, DBP ELISA Test - 96T
450.00 € 450.0 EUR
[0866-RD-VIM-Hu-96Tests] Human Vimentin (VIM) ELISA Test, 96 tests
Human Vimentin (VIM) ELISA Test, 96 tests
849.00 € 849.0 EUR
[0812-SLY4190Hu-96T] Human Vibrio cholerae ELISA Test - 96T
Human Vibrio cholerae ELISA Test - 96T
650.00 € 650.0 EUR
[0586-DL-VRK1-Hu-96] Human Vaccinia Related Kinase 1 (VRK1) ELISA Test-96T
Human Vaccinia Related Kinase 1 (VRK1) ELISA Test-96T
690.00 € 690.0 EUR
[0763-E-EL-H1094] Human VIM(Vimentin) ELISA Test, 96 test
Human VIM(Vimentin) ELISA Test, 96 test
839.00 € 839.0 EUR
[0763-E-EL-H0111] Human VEGF-A (Vascular Endothelial Cell Growth Factor A) ELISA Test - 96 wells plate
Human VEGF-A (Vascular Endothelial Cell Growth Factor A) ELISA Test - 96 wells plate
566.00 € 566.0 EUR
[0855-ELK4666] Human VAMP2(Vesicle Associated Membrane Protein 2) ELISA Test, 96 test  A.C. Supply s.a.s.
Human VAMP2(Vesicle Associated Membrane Protein 2) ELISA Test, 96 test A.C. Supply s.a.s.
432.00 € 432.0 EUR
[0399-CSB-EL004345HU-96T] Human Uncharacterized protein C9orf72 (C9orf72) ELISA Test - 96 wells plate
Human Uncharacterized protein C9orf72 (C9orf72) ELISA Test - 96 wells plate
1,032.00 € 1032.0 EUR
[0399-CSB-EL004345HU-5X96T] Human Uncharacterized protein C9orf72 (C9orf72) ELISA Test - 5x96 wells plate
Human Uncharacterized protein C9orf72 (C9orf72) ELISA Test - 5x96 wells plate
3,144.00 € 3144.0 EUR
[0399-CSB-EL004345HU-10X96T] Human Uncharacterized protein C9orf72 (C9orf72) ELISA Test - 10x96 wells plate
Human Uncharacterized protein C9orf72 (C9orf72) ELISA Test - 10x96 wells plate
5,955.00 € 5955.0 EUR
[0617-EKC35992] Human Uncharacterized protein C9orf72  Elisa Test 96T
Human Uncharacterized protein C9orf72 Elisa Test 96T
1,184.00 € 1184.0 EUR
[0544-MBS106491-96] Human Ubiquitin Carboxyl Terminal Hydrolase L1 ELISA Test, 96T
Human Ubiquitin Carboxyl Terminal Hydrolase L1 ELISA Test, 96T
996.00 € 996.0 EUR
[0399-CSB-E04740h-96T] Human Tumor necrosis factor α,TNF-α ELISA Test - 96T
Human Tumor necrosis factor α,TNF-α ELISA Test - 96T
950.00 € 950.0 EUR
[0006-E01T0008-96T] Human Tumor Necrosis Factor Alpha ELISA Test, 96 tests
Human Tumor Necrosis Factor Alpha ELISA Test, 96 tests
775.00 € 775.0 EUR
[0445-6801] Human Tumor Necrosis Factor Alpha Detection ELISA Test, 96 test
Human Tumor Necrosis Factor Alpha Detection ELISA Test, 96 test
594.00 € 594.0 EUR
[0812-SL3332Hu- 96W] Human Trypanosoma evansi (T. evansi) ELISA Test - 96 Wells
Human Trypanosoma evansi (T. evansi) ELISA Test - 96 Wells
500.00 € 500.0 EUR
[0820-ELI-02011h] Human Troponin I, fast skeletal muscle (TNNI2) ELISA Test - 96 wells plate
Human Troponin I, fast skeletal muscle (TNNI2) ELISA Test - 96 wells plate
985.00 € 985.0 EUR
[0006-E01T0881-96] Human Trimethylamine-N-oxide reductase ELISA Test, 96T
Human Trimethylamine-N-oxide reductase ELISA Test, 96T
822.00 € 822.0 EUR
  • 53
  • 54
  • 55
  • 56
  • 57

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)